Biography
Biography
Evan Kubota brings substantial experience in all stages of litigation, from pre-suit investigation and strategic advice through motion practice, discovery, trial, and appeal. His experience includes complex securities and derivative actions, bankruptcy confirmation and adversary proceedings, and regulatory investigations. He has taken and defended numerous depositions, worked closely with damages and industry experts, presented at mediations, and participated in several trials.
Evan was a member of the teams prosecuting the successfully resolved cases against Teva Pharmaceutical Industries, Ltd., Granite Construction Incorporated, and Gatos Silver, Inc. (settlement pending), and is currently litigating class actions against Talis Biomedical Corp., Bioventus Inc., and TaskUs, Inc., as well as sovereign debt litigation against Sri Lanka and the Republic of Argentina.
Prior to joining BFA in 2019, Evan was an associate at Paul, Weiss, Rifkind, Wharton & Garrison LLP for nine years, where he litigated high-profile matters on behalf of financial institutions and issuers in a variety of industries. Representative matters include plaintiff's counsel in breach of contract, fraud and civil RICO litigations against a distressed insurance company; debtor's counsel in a leading media company's Chapter 11 bankruptcy, which eliminated over $1 billion in debt; and the defense of numerous RMBS-related litigations, arbitrations, and investigations in the wake of the financial crisis.
Evan earned a B.A. from the University of Florida, cum laude, in 2007 and a J.D. from Harvard Law School, cum laude, in 2010. He is admitted to practice in New York (2011), as well as the U.S. District Courts for the Southern and Eastern Districts of New York (2011).
PRACTICES & SERVICES
EDUCATION
Harvard Law School
J.D., cum laude, 2010
University of Florida
B.A., cum laude, 2007
J.D., cum laude, 2010
University of Florida
B.A., cum laude, 2007
ADMISSIONS
New York (2011)
U.S. District Courts:
U.S. District Courts:
- S.D.N.Y. (2011)
- E.D.N.Y. (2011)
Cases
Background: This case arises from CVS’s misrepresentations regarding its ability to control medical costs and health care utilization patterns in its Health Care Benefits segment. During the relevant period, the company represented that its “integrated health care model . . . lowers overall health care costs” and that its “Health Care Benefits segment is expected to continue to benefit from Medicare and Commercial membership growth.” In truth, however, CVS concealed the impact that escalating medical cost trends and health care utilization patterns had on the company at the time.
BFA's Role: BFA was appointed as Co-Lead Counsel for the putative class on December 5, 2024.
Status: BFA is preparing the amended complaint.
BFA's Role: BFA was appointed as Co-Lead Counsel for the putative class on December 5, 2024.
Status: BFA is preparing the amended complaint.